Capha Pharmaceuticals Stock Fundamentals
Capha Pharmaceuticals fundamentals help investors to digest information that contributes to Capha Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Capha OTC Stock. The fundamental analysis module provides a way to measure Capha Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Capha Pharmaceuticals otc stock.
Capha |
Capha Pharmaceuticals OTC Stock Current Valuation Analysis
Capha Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Capha Pharmaceuticals Current Valuation | 290.34 K |
Most of Capha Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Capha Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Capha Pharmaceuticals has a Current Valuation of 290.34 K. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.
Capha Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Capha Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Capha Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Capha Pharmaceuticals competition to find correlations between indicators driving Capha Pharmaceuticals's intrinsic value. More Info.Capha Pharmaceuticals is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Capha Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Capha Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Capha Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Capha Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Capha Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Capha Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Capha Pharmaceuticals by comparing valuation metrics of similar companies.Capha Pharmaceuticals is currently under evaluation in current valuation category among related companies.
Capha Fundamentals
| Return On Equity | -20.45 | |||
| Return On Asset | -703.42 | |||
| Current Valuation | 290.34 K | |||
| Shares Outstanding | 64.43 M | |||
| Price To Earning | (0.01) X | |||
| Price To Book | 25.00 X | |||
| EBITDA | (47.42 K) | |||
| Net Income | (64.04 K) | |||
| Cash And Equivalents | 674 | |||
| Total Debt | 284.57 K | |||
| Debt To Equity | 0.75 % | |||
| Current Ratio | 0.01 X | |||
| Cash Flow From Operations | (107.38 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | 124.23 | |||
| Market Capitalization | 6.4 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Capha Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Capha Pharmaceuticals' short interest history, or implied volatility extrapolated from Capha Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Capha OTC Stock
If you are still planning to invest in Capha Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Capha Pharmaceuticals' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |